• Drug: Mavyret (glecaprevir/pibrentasvir)
  • Manufacturer: AbbVie

  • Route of Administration: Oral

  • Site of Care: Outpatient

  • Approved Indication:

    • treatment of adults and pediatric patients 3 years of age and older with chronic HCV genotype 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis
    • treatment of adult and pediatric patients 3 years of age and older with HCV genotype 1 infection who previously have been treated with a regimen containing an HCV NS5A or an NS3/4A protease inhibitor, but not both

  • Disease: chronic viral hepatitis C

  • Therapeutic Area: Infectious disease, Gastroenterology, Hepatology
  • Enrollment Form Link: mavyret.com/nurse-ambassador
  • Phone Number: 1-877-MAVYRET (1-877-628-9738)
  • Fax Number: 1-866-938-6696
  • Product Website: mavyret.com